Lyell Wealth Management
BIIB icon

Lyell Wealth Management’s Biogen BIIB Stock Holding History

Lyell Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$209K Buy
+925
New +$196K 0.01% 222

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Lyell Wealth Management's BIIB Position: Q3 2026 in Review

Lyell Wealth Management opened a new position in Biogen (BIIB) in Q3 2026: 925 shares worth $209K. The stake represents 0.01% of the portfolio and ranks #222 among its holdings.

643 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Lyell Wealth Management held 925 shares of Biogen worth $209K as of Q3 2026.
  • Biogen was a new Lyell Wealth Management position in Q3 2026.
  • Biogen made up 0.01% of Lyell Wealth Management's portfolio in Q3 2026, its #222 holding.
  • 643 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Lyell Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.